Association between the introduction of a national targeted intervention program and the incidence of surgical site infections in Swiss acute care hospitals.
Hair removal
Multimodal intervention bundles
Perioperative antimicrobial prophylaxis
Preoperative management
Skin disinfection
Surgical site infection
Surveillance
Journal
Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411
Informations de publication
Date de publication:
24 Nov 2023
24 Nov 2023
Historique:
received:
07
10
2023
accepted:
14
11
2023
medline:
27
11
2023
pubmed:
24
11
2023
entrez:
24
11
2023
Statut:
epublish
Résumé
In Switzerland, the national surgical site infection (SSI) surveillance program showed a modest decrease in SSI rates for different procedures over the last decade. The study aimed to determine whether a multimodal, targeted intervention program in addition to existing SSI surveillance is associated with decreased SSI rates in the participating hospitals. Prospective multicenter pre- and postintervention study conducted in eight Swiss acute care hospitals between 2013 and 2020. All consecutive patients > 18 years undergoing cardiac, colon, or hip/knee replacement surgery were included. The follow-up period was 30 days and one year for implant-related surgery. Patients with at least one follow-up were included. The intervention was to optimize three elements of preoperative management: (i) hair removal; (ii) skin disinfection; and (iii) perioperative antimicrobial prophylaxis. We compared SSI incidence rates (main outcome measure) pre- and postintervention (three years each) adjusted for potential confounders. Poisson generalized linear mixed models fitted to quarter-yearly confirmed SSIs and adjusted for baseline differences between hospitals and procedures. Adherence was routinely monitored through on-site visits. A total of 10 151 patients were included, with a similar median age pre- and postintervention (69.6 and IQR 60.9, 76.8 years, vs 69.5 and IQR 60.4, 76.8 years, respectively; P = 0.55) and similar proportions of females (44.8% vs. 46.1%, respectively; P = 0.227). Preintervention, 309 SSIs occurred in 5 489 patients (5.6%), compared to 226 infections in 4 662 cases (4.8%, P = 0.09) postintervention. The adjusted incidence rate ratio (aIRR) for overall SSI after intervention implementation was 0.81 (95% CI, 0.68 to 0.96, P = 0.02). For cardiac surgery (n = 2 927), the aIRR of SSI was 0.48 (95% CI, 0.32 to 0.72, P < 0.001). For hip/knee replacement surgery (n = 4 522), the aIRR was 0.88 (95% CI, 0.52 to 1.48, P = 0.63), and for colon surgery (n = 2 702), the aIRR was 0.92 (95% CI, 0.75 to 1.14, P = 0.49). The SSI intervention bundle was associated with a statistically significant decrease in SSI cases. A significant association was observed for cardiac surgery. Adding a specific intervention program can add value compared to routine surveillance only. Further prevention modules might be necessary for colon and orthopedic surgery.
Sections du résumé
BACKGROUND
BACKGROUND
In Switzerland, the national surgical site infection (SSI) surveillance program showed a modest decrease in SSI rates for different procedures over the last decade. The study aimed to determine whether a multimodal, targeted intervention program in addition to existing SSI surveillance is associated with decreased SSI rates in the participating hospitals.
METHODS
METHODS
Prospective multicenter pre- and postintervention study conducted in eight Swiss acute care hospitals between 2013 and 2020. All consecutive patients > 18 years undergoing cardiac, colon, or hip/knee replacement surgery were included. The follow-up period was 30 days and one year for implant-related surgery. Patients with at least one follow-up were included. The intervention was to optimize three elements of preoperative management: (i) hair removal; (ii) skin disinfection; and (iii) perioperative antimicrobial prophylaxis. We compared SSI incidence rates (main outcome measure) pre- and postintervention (three years each) adjusted for potential confounders. Poisson generalized linear mixed models fitted to quarter-yearly confirmed SSIs and adjusted for baseline differences between hospitals and procedures. Adherence was routinely monitored through on-site visits.
RESULTS
RESULTS
A total of 10 151 patients were included, with a similar median age pre- and postintervention (69.6 and IQR 60.9, 76.8 years, vs 69.5 and IQR 60.4, 76.8 years, respectively; P = 0.55) and similar proportions of females (44.8% vs. 46.1%, respectively; P = 0.227). Preintervention, 309 SSIs occurred in 5 489 patients (5.6%), compared to 226 infections in 4 662 cases (4.8%, P = 0.09) postintervention. The adjusted incidence rate ratio (aIRR) for overall SSI after intervention implementation was 0.81 (95% CI, 0.68 to 0.96, P = 0.02). For cardiac surgery (n = 2 927), the aIRR of SSI was 0.48 (95% CI, 0.32 to 0.72, P < 0.001). For hip/knee replacement surgery (n = 4 522), the aIRR was 0.88 (95% CI, 0.52 to 1.48, P = 0.63), and for colon surgery (n = 2 702), the aIRR was 0.92 (95% CI, 0.75 to 1.14, P = 0.49).
CONCLUSIONS
CONCLUSIONS
The SSI intervention bundle was associated with a statistically significant decrease in SSI cases. A significant association was observed for cardiac surgery. Adding a specific intervention program can add value compared to routine surveillance only. Further prevention modules might be necessary for colon and orthopedic surgery.
Identifiants
pubmed: 37996935
doi: 10.1186/s13756-023-01336-7
pii: 10.1186/s13756-023-01336-7
pmc: PMC10668371
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
134Investigateurs
Carlo Balmelli
(C)
Delphine Berthod
(D)
Niccolò Buetti
(N)
Stephan Harbarth
(S)
Philipp Jent
(P)
Jonas Marschall
(J)
Hugo Sax
(H)
Laurence Senn
(L)
Sarah Tschudin Sutter
(ST)
Aline Wolfensberger
(A)
Walter Zingg
(W)
Informations de copyright
© 2023. The Author(s).
Références
Infect Control Hosp Epidemiol. 2017 Jun;38(6):697-704
pubmed: 28558862
JAMA. 2005 Oct 26;294(16):2035-42
pubmed: 16249417
Antimicrob Resist Infect Control. 2020 Jul 31;9(1):120
pubmed: 32736650
JAMA Netw Open. 2021 Dec 1;4(12):e2138926
pubmed: 34910149
Lancet Infect Dis. 2016 Dec;16(12):e276-e287
pubmed: 27816413
Arch Surg. 2011 Mar;146(3):263-9
pubmed: 21079110
BMJ. 2022 Nov 3;379:e071476
pubmed: 36328372
Infect Control Hosp Epidemiol. 2018 Nov;39(11):1277-1295
pubmed: 30234463
JAMA. 2015 Jun 2;313(21):2162-71
pubmed: 26034956
JAMA Surg. 2014 Oct;149(10):1045-52
pubmed: 25163027
BMJ Qual Saf. 2016 Dec;25(12):986-992
pubmed: 26369893
J Hosp Infect. 2018 Dec;100(4):411-420
pubmed: 29885873
Swiss Med Wkly. 2012 Sep 04;142:w13616
pubmed: 22949137
J Hosp Infect. 2019 Jul;102(3):267-276
pubmed: 30529703
Infect Control Hosp Epidemiol. 2008 Oct;29 Suppl 1:S51-61
pubmed: 18840089
JAMA Surg. 2017 Aug 01;152(8):784-791
pubmed: 28467526
Surg Infect (Larchmt). 2013 Feb;14(1):73-156
pubmed: 23461695
Infect Control Hosp Epidemiol. 2020 Jul;41(7):805-812
pubmed: 32389140
N Engl J Med. 2010 Jan 7;362(1):18-26
pubmed: 20054046
J Hosp Infect. 2009 Jul;72(3):193-201
pubmed: 19482375
Infect Control Hosp Epidemiol. 2017 Oct;38(10):1172-1181
pubmed: 28826412
Infect Control Hosp Epidemiol. 1999 Apr;20(4):250-78; quiz 279-80
pubmed: 10219875
J Clin Med. 2021 Sep 29;10(19):
pubmed: 34640542
Lancet Infect Dis. 2016 Dec;16(12):e288-e303
pubmed: 27816414
JAMA Netw Open. 2018 Oct 5;1(6):e183226
pubmed: 30646234
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Am J Infect Control. 2009 Dec;37(10):783-805
pubmed: 20004811
PLoS One. 2017 Sep 6;12(9):e0184200
pubmed: 28877223
Int J Surg. 2021 Nov;95:106149
pubmed: 34687953